Bone Agents Underused, and Declining, in Prostate Cancer

Many patients with metastatic castration-resistant prostate cancer are not receiving bone-modifying agents, despite guideline endorsement.
Medscape Medical News

source https://www.medscape.com/viewarticle/bone-agents-underused-and-declining-prostate-cancer-2026a1000lih?src=rss